+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Vancomycin-resistant enterococci - the nature of resistance and risk of transmission from animals to humans



Vancomycin-resistant enterococci - the nature of resistance and risk of transmission from animals to humans



Klinicka Mikrobiologie a Infekcni Lekarstvi 22(2): 54-60



Enterococci are part of the normal intestinal flora of humans and animals. Under certain circumstances, they are capable of extraintestinal conversion to opportunistic pathogens. They cause endogenous as well as exogenous community and nosocomial infections. The gastrointestinal tract of mammals provides them with favorable conditions for acquisition and spread of resistance genes, for example to vancomycin (van), from other symbiotic bacteria. Thus, vancomycin-resistant enterococci (VRE) become potential reservoirs and vectors of the van genes. Their occurrence in the population of the Czech Republic was first reported by Kolář et al. in 1997. Some variants of the vanA gene cluster carried on Tn1546 which encode resistance to vancomycin are identical in humans and in animals. It means that animals, especially cattle, poultry and pigs, could be an important reservoir of VRE for humans. Kolář and Bardoň detected VRE in animals in the Czech Republic for the first time in 2000. In Europe, the glycopeptide antibiotic avoparcin, used as a growth stimulator, is responsible for selection of VRE strains in animals. Strains of Enterococcus faecium from animals may offer genes of antimicrobial resistance to other enterococci or they can be directly dangerous to human. This is demonstrated by finding isolates of E. faecalis from human patients and from pigs having very similar profiles of resistance and virulence genes. The goal of the paper was to point out the similarity between isolates of human and animal strains of enterococci resistant to vancomycin, and the possibility of their bilateral transfer between humans and animals.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059232690

Download citation: RISBibTeXText

PMID: 27450523


Related references

Possibility of vancomycin-resistant enterococci transmission from human to broilers, and possibility of using the vancomycin-resistant gram-positive cocci as a model in a screening study of vancomycin-resistant enterococci infection in the broiler chick. Animal Science Journal 77(5): 538-544, 2006

Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: evidence for transmission of vancomycin resistance from animals to humans?. Antimicrobial Agents and ChemoTherapy 43(9): 2215-2221, 1999

Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms. Microbial Drug Resistance 4(4): 313-318, 1998

The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide. American Journal of Infection Control 30(1): 40-43, 2002

In-vitro susceptibility to Ly333328 of vancomycin-resistant enterococci isolated from humans and animals. Journal of Antimicrobial Chemotherapy 40(5): 733-734, 1997

Characterization of vanA vancomycin-resistant enterococci isolated from humans and animals in Taiwan. Abstracts of the General Meeting of the American Society for Microbiology 103: C-412, 2003

In-vitro susceptibility to LY333328 of vancomycin-resistant enterococci isolated from humans and animals. Journal of Antimicrobial ChemoTherapy 40(5): 733-734, 1997

Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions. Applied and Environmental Microbiology 71(9): 5383-5390, 2005

Occurrence of vancomycin-resistant enterococci in humans and animals in the Czech Republic between 2002 and 2004. Journal of Medical Microbiology 54(Pt 10): 965-967, 2005

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci. Brazilian Journal of Infectious Diseases 19(1): 58-61, 2015

Prevalence and molecular epidemiology of vancomycin-resistant enterococci (VRE) strains isolated from animals and humans in Korea. Korean Journal of Internal Medicine 20(1): 55-62, 2005

Vancomycin-resistant enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance. Chest 123(5 Suppl.): 504s-518s, 2003

Low risk of apparent transmission of vancomycin-resistant Enterococci from bacteraemic patients to hospitalized contacts. American Journal of Infection Control 41(9): 778-781, 2013

Characterization of fecal vancomycin-resistant enterococci with acquired and intrinsic resistance mechanisms in wild animals, Spain. Microbial Ecology 72(4): 813-820, 2016

Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clinical Infectious Diseases 35(10): 1139-1146, 2002